Cardiolipin Side Chain Composition Controls Metabolic Switching and Regulates Oxidative Phosphorylation
Cardiolipin Side Chain Composition Controls Metabolic Switching and [...]
The lysine desuccinylase SIRT5 regulates hepatic metabolism of medium-chain fatty acids
The lysine desuccinylase SIRT5 regulates hepatic metabolism of [...]
Enhancement of VLCAD activity in VLCAD knockout mouse embryonic fibroblasts with novel mRNA technology
Enhancement of VLCAD activity in VLCAD knockout mouse [...]
Riboflavin-responsive disorders: an overview
Riboflavin-responsive disorders: an overview [...]
Activation and alleviation of cellular stress responses in fatty acid oxidation disorders
Activation and alleviation of cellular stress responses in [...]
Tissue-Specific Roles of Fatty Acid Oxidation
Tissue-Specific Roles of Fatty Acid Oxidation [...]
Difficult management of an 8 year old patient
Difficult management of an 8 year old patient [...]
Experimental evidence that fatty acids accumulating in VLCAD deficiency disrupt mitochondrial respiration in heart, liver and brain of young rats
Experimental evidence that fatty acids accumulating in VLCAD [...]
Dietary Management of Carnitine Transporter Deficiency with Carnitine Diet
Dietary Management of Carnitine Transporter Deficiency with Carnitine [...]
Dilated Cardiyomyopathy Due to Primary Carnitine Deficiency: A Real Life Case Study
Dilated Cardiyomyopathy Due to Primary Carnitine Deficiency: A [...]
-
Normal insulin sensitivity in a patient with very long-chain acylCoA dehydrogenase (VLCAD) deficiency during a hyperinsulinemic-euglycemic clamp (HEC) with an intralipid Infusion GalleryNormal insulin sensitivity in a patient with very long-chain acylCoA dehydrogenase (VLCAD) deficiency during a hyperinsulinemic-euglycemic clamp (HEC) with an intralipid Infusion
Normal insulin sensitivity in a patient with very long-chain acylCoA dehydrogenase (VLCAD) deficiency during a hyperinsulinemic-euglycemic clamp (HEC) with an intralipid Infusion
Normal insulin sensitivity in a patient with very [...]
EXPRESSION OF NOVEL MUTATIONS IN THE CARNITNE TRANSPORTER FROM PATIENTS WITH PRIMARY CARNITINE DEFICIENCY.
EXPRESSION OF NOVEL MUTATIONS IN THE CARNITNE TRANSPORTER [...]
Unlocking the Future
We are committed to discovering new FAOD treatments and cures to improve the lives of our patients and their families.
